Pay in 4 interest-free payments of $7.45 Learn more
Ships within 48 hours · Estimated delivery Sep 18 - Sep 23
trump glp 1 executive order secures Eli Lilly, Novo Medicare deals to cut GLP-1 prices Ascendis Pharma has granted searchfilter_Reduce food intake Dosing:Low-Dose
Ascendis Pharma has granted Novo Nordisk an exclusive worldwide license for the TransCon platform to develop and commercialize products for metabolic diseases, including obesity and type 2 diabetes, along with a product-specific
Mechanisms Mediating the Diuretic and Natriuretic Actions of the Incretin Hormone Glucagon-Like Peptide-1
searchfilter_Reduce food intake
Dosing:Low-Dose
Fang, C
US$ 27.35
US$ 29.64
US$ 27.31
US$ 29.61
US$ 27.01
US$ 25.38
US$ 23.11
US$ 26.77
US$ 29.00
